Holen Sie sich die Stockscreener-App
3.35
10.93%
0.33
Handel nachbörslich:
3.38
0.03
+0.90%
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
Is ReShape Lifesciences Inc. a good long term investmentHigh-margin investment plays - Autocar Professional
ReShape Lifesciences Inc. Stock Analysis and ForecastExplosive trading opportunities - jammulinksnews.com
What analysts say about ReShape Lifesciences Inc. stockExceptional risk-adjusted gains - printweek.in
ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire
ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest
ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga
ReShape Lifesciences Strategic Transformation: Board and Proxy Advisors Unite Behind Vyome Merger - Stock Titan
What drives ReShape Lifesciences Inc. stock priceUnmatched profit growth - jammulinksnews.com
How high can ReShape Lifesciences Inc. stock price go in 2025Free Access to Community - Newser
ReShape Lifesciences Announces Merger with Vyome Therapeutics - The Globe and Mail
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
What makes ReShape Lifesciences Inc. stock price move sharplyFree Join Group - Newser
How ReShape Lifesciences Inc. stock performs during market volatilityFree Capital Growth Strategies - Newser
ReShape Lifesciences announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria
ReShape Lifesciences Loans $200K to Vyome Therapeutics - TipRanks
ReShape Lifesciences to receive patent for swallowable balloon device - Investing.com
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - The Manila Times
Game-Changing Patent: ReShape's New Self-Degrading Weight Loss Balloon Could Transform Obesity Treatment - Stock Titan
RSLS 425及美國證券交易委員會申報文件 - Yahoo 財經
ReShape Lifesciences: Navigating Regulatory Recovery – Is This Turnaround Sustainable? - AInvest
ReShape Lifesciences regains Nasdaq compliance after equity raises By Investing.com - Investing.com South Africa
ReShape Lifesciences regains Nasdaq compliance after equity raises - Investing.com
ReShape Lifesciences cuts workforce to save $750k annually - Investing.com
About Us - FinancialContent
Revolutionary Diabetes Treatment: ReShape's New Neuromodulation Tech Targets Blood Sugar Without Drugs - Stock Titan
ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum By Investing.com - Investing.com India
ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum - Investing.com
ReShape Lifesciences Raises Equity to Avoid Delisting - TipRanks
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
Why Did ReShape Lifesciences Plunge 12.54%? Public Offering Concerns - AInvest
ReShape Lifesciences Closes $2.6M Stock Offering - TipRanks
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):